Skip to main content
US EQUITIES AFTER-HOURS CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
PR

PRHSXETF / FundT. Rowe Price Health Sciences Fund, Inc.

Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment PRHSX's does — no target price to set, unlike a price alert.

Could not fetch a live price for this symbol.
Sharia status
NOT COMPLIANT
Screened by look-through to its filed holdings — 83% of portfolio weight covered
Fund look-through

T. Rowe Price Health Sciences Fund, Inc. · T. ROWE PRICE HEALTH SCIENCES FUND, INC.

279 holdings

NON-COMPLIANT 22.80% of portfolio weight is in non-compliant holdings, over the 5% threshold.

279 holdings, 116 matched (83% of weight). Portfolio as of 2026-06-30, filed 2026-08-27. Source: SEC Form N-PORT.

3.87% of this portfolio’s income is non-permissible — weighted across holdings, computed over 65% of portfolio weight (85 of 279 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.

60.3% compliant 0.0% questionable 22.8% non-compliant 16.9% unscreened

All holdings (279) · showing 251–279
HoldingStatusWeightEvery methodology, and the debt ratio behind it
Mirum Pharma Escrow Expense Fund PP UNSCREENED 0.00% no in-house ratios for this holding
Mirum Pharma Escrow Working Capital PP UNSCREENED 0.00% no in-house ratios for this holding
Chromacode INC SER AA CVT PFD STK PP UNSCREENED 0.00% no in-house ratios for this holding
AFFINIVAX EXPENSE FUND PP UNSCREENED 0.00% no in-house ratios for this holding
REFLEXION MEDICAL INC CVT PFD SR C-X PP UNSCREENED 0.00% no in-house ratios for this holding
REFLEXION MEDICAL INC CVT PFD SR E-X PP UNSCREENED 0.00% no in-house ratios for this holding
REFLEXION MEDICAL SER F CVT PFD STOCK PP UNSCREENED 0.00% no in-house ratios for this holding
REFLEXION MEDICAL INC CVT PFD SR D-X PP UNSCREENED 0.00% no in-house ratios for this holding
CHROMACODE INC PP UNSCREENED 0.00% no in-house ratios for this holding
GENEDX HOLDINGS CORP WTS 7/26 UNSCREENED 0.00% no in-house ratios for this holding
Blue Marlin Therapeutics Common Stock PP UNSCREENED 0.00% no in-house ratios for this holding
PROFOUNDBIO EXPENSE FUND PAYMENT PP UNSCREENED 0.00% no in-house ratios for this holding
EXACT SCIENCES CMO MILESTONE PP UNSCREENED 0.00% no in-house ratios for this holding
AFFINIVAX AFX3772 MILESTONE EVENT PP UNSCREENED 0.00% no in-house ratios for this holding
AFFINIVAX NEXT GEN PROD MILESTON EVNT PP UNSCREENED 0.00% no in-house ratios for this holding
EXACT SCIENCES FDA MILESTONE PP UNSCREENED 0.00% no in-house ratios for this holding
GENERATION BIO CO UNSCREENED 0.00% no in-house ratios for this holding
GYROSCOPE THERAPEUTICS MLSTNE PYMT 1 PP UNSCREENED 0.00% no in-house ratios for this holding
GYROSCOPE THERAPEUTICS MLSTNE PYMT 2 PP UNSCREENED 0.00% no in-house ratios for this holding
GYROSCOPE THERAPEUTICS MLSTNE PYMT 3 PP UNSCREENED 0.00% no in-house ratios for this holding
GINKGO BIOWORKS HLDS ERN OUT SHS 600 PP UNSCREENED 0.00% no in-house ratios for this holding
GINKGO BIOWORKS HLDS ERN OUT SHS 700 PP UNSCREENED 0.00% no in-house ratios for this holding
GINKGO BIOWORKS HLDS ERN OUT SH 800 PP UNSCREENED 0.00% no in-house ratios for this holding
Medici Tx Platform $3 mil Milestone PP UNSCREENED 0.00% no in-house ratios for this holding
Mirum Pharma Milestone $500 mil PP UNSCREENED 0.00% no in-house ratios for this holding
Mirum Pharma Milestone $750 mil PP UNSCREENED 0.00% no in-house ratios for this holding
RING THERAPEUTICS INC PP UNSCREENED 0.00% no in-house ratios for this holding
Saluda Med Common WTS 3/26 PP UNSCREENED 0.00% no in-house ratios for this holding
SOMALOGIC INC WTS 8/26 UNSCREENED 0.00% no in-house ratios for this holding

The published standards disagree about this fund by 42 points of portfolio weight — 67.4% of it passes AAOIFI, 25.6% passes MSCI Islamic. Which number is yours depends on which standard you follow.

These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.

ratios pass on 67.4% ratios fail on 14.3% 18.5% not rated under AAOIFI

116 of 279 listed holdings carry our own per-methodology verdicts (83% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 106 (80% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.

Non-compliant holdingWeight
UNH UNITEDHEALTH GROUP INC 5.99%
BMY BRISTOL-MYERS SQUIBB CO 2.11%
ELV ELEVANCE HEALTH INC 1.53%
RPRX ROYALTY PHARMA PLC- CL A 0.97%
CVS CVS HEALTH CORP 0.94%
THC TENET HEALTHCARE CORP 0.94%
KYMR KYMERA THERAPEUTICS INC 0.89%
PTGX PROTAGONIST THERAPEUTICS INC 0.85%
RVMDW REVOLUTION MEDICINES INC 0.78%
VTRS VIATRIS INC 0.66%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

T. Rowe Price Health Sciences Fund, Inc. (PRHSX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.

Screened on its holdings, not its name

HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.

60.4%Compliant 22.8%Non-compliant 16.9%Not screened
HoldingWeightVerdict
LLYELI LILLY & CO 14.28% Compliant
JNJJOHNSON & JOHNSON 6.63% Compliant
UNHUNITEDHEALTH GROUP INC 5.99% Non-compliant
ABBVABBVIE INC 5.10% Compliant
MRKMERCK & CO. INC. 4.01% Compliant
GILDGILEAD SCIENCES INC 2.82% Compliant
TMOTHERMO FISHER SCIENTIFIC INC 2.52% Compliant
VRTXVERTEX PHARMACEUTICALS INC 2.28% Compliant
BMYBRISTOL-MYERS SQUIBB CO 2.11% Non-compliant
ABTABBOTT LABORATORIES 1.89% Compliant

Top 10 of 279 holdings, 47.6% of the fund by weight. Every holding is screened, not only these.

What holds the number back

The positions keeping this fund short of 100% compliant by weight.

  • UNHnon-compliant5.99%
  • BMYnon-compliant2.11%
  • ELVnon-compliant1.53%
  • RPRXnon-compliant0.97%
  • CVSnon-compliant0.94%
  • THCnon-compliant0.94%

What changed, and when

Verdict history for PRHSX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for PRHSX has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

102.3895.5888.7981.9975.202025-11-202026-05-222026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance

This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
90.74 – 94.62
±2.09% from 92.68, made 2026-09-14 · resolves 2026-09-21
SELL
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSELL
5 buy · 0 neutral · 7 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)42.80NEUTRAL
Stochastic %K (14)0.00BUY
CCI (20)-137.95BUY
Williams %R (14)-100.00BUY
MACD (12,26,9)-0.53SELL
ROC (10)-5.66SELL
Momentum (10)-5.79SELL
EMA (10)99.62SELL
SMA (10)100.29SELL
EMA (20)99.22SELL
SMA (20)99.75SELL
EMA (30)98.49SELL
SMA (30)98.12SELL
EMA (50)97.17SELL
SMA (50)96.48BUY
EMA (100)94.28BUY
SMA (100)94.61BUY
EMA (200)89.41BUY
SMA (200)87.71BUY

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

No usable intraday or daily bars came back for this listing, so there is no structure to read.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is a fund screened on its name?

No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.

What does unrated weight mean?

It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.

Does the issuer's board make it compliant?

It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.

How often is this re-screened?

When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.